OPKO Health Says FDA Accepts Resubmission Of NDA For Its RAYALDEE By: Benzinga via Benzinga April 27, 2016 at 14:10 PM EDT OPKO Health, Inc. (NYSE: OPK) disclosed that the FDA in the United States accepted its resubmission of the New Drug Application (NDA) ... Read More >>